$QNT

Stepniak Michal purchased $800K of QNT

Stepniak Michal purchased 13,333 shares of Quantinuum Inc. (QNT) at $60.00 ($0.80M total) on 2026-06-05.

Original reporting
SEC EDGAR · Stepniak Michal
Published Jun 8, 2026, 8:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 8, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$QNT
Bullish
medium confidence
Mentioned
$QNT
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QNTBullishLow
01

Why it matters

The newest fact is the director’s disclosed purchase size and price ($60/share) on June 5, which may slightly improve sentiment but does not change operating outlook.

02

Market read

A single director open-market buy (~$0.8M) is a modest positive signal, but it is unlikely to drive a sustained repricing without additional fundamental catalysts.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, but it still doesn’t explain motivation or whether other insiders/large holders are changing positions.

Relevance 6/10Novelty 8/10Timing: filed June 8; purchase dated June 5

Background

The article reports a Quantinuum (QNT) Form 4 insider transaction filed with the SEC (open-market purchase by a director).

Company-level read

Ticker impact

$QNTBullishMedium confidence
Context

Director Stepniak Michal bought 13,333 shares of Quantinuum (QNT) for ~$799,980 via an open-market purchase disclosed on Form 4.

Expected impact

Likely limited near-term impact; any effect should be small and fade unless followed by additional disclosures.

Evidence & confidence

The article is a primary insider transaction with a clear buy size, but it provides no new company performance, guidance, or deal information.

Market effects

No sector read-across; this is company-specific insider ownership activity.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine (compensation, diversification, or non-informational timing) and may not reflect near-term fundamentals.

Key entities

  • Quantinuum Inc.

    Subject of the SEC Form 4 insider transaction; director Stepniak Michal purchased shares.

  • Stepniak Michal

    Director who executed the open-market purchase of 13,333 QNT shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QNTMed

Quantinuum vs. IonQ: Why One Major Wall Street Firm Says This Stock Is the Better Bet

Morgan Stanley upgraded Quantinuum (QNT) to overweight with a $68 price target, citing its leadership in quantum error correction and execution. IonQ (IONQ) kept at equal-weight with a $43 target. Quantinuum leads in error correction, while IonQ has advantages in manufacturability and scalability. Both companies are key players in the quantum computing sector, with Morgan Stanley forecasting a $100B market by 2040.

High

Morgan Stanley Names Quantinuum 'Top Pick,' Sets $62 Price Target

Morgan Stanley upgraded Quantinuum to 'Overweight' with a $62 price target, citing its technological edge in error-correction. Quantinuum shares rose 11.05% to $36.68. Morgan Stanley's analyst noted the company's lead in quantum computing technology, though commercialization remains years away. The stock trades below its 52-week high, and Wall Street's average target is $97.

$QNTHigh

Morgan Stanley Names New Top Quantum Computing Stock

Morgan Stanley upgraded Quantinuum (QNT) to Overweight, citing its leadership in quantum computing technology and execution. Shares rose 4.6% premarket. The bank sees a $100B+ market by 2040 but notes valuation gaps. Morgan Stanley lowered its price target to $62. It also rated IonQ (IONQ), Infleqtion (INFQ), and Xanadu (XNDU) as Equal-Weight.

Med

Morgan Stanley Upgrades Quantinuum, Projects $100 Billion Market

Morgan Stanley upgraded Quantinuum to Overweight, setting a $62 price target, 88% above its recent close. The bank forecasts the quantum computing market could exceed $100 billion annually by 2040, with $10 billion by 2030, contingent on fault-tolerant systems. Quantinuum's revenue is projected at $270 million in 2028 and $2 billion in 2030. The 2027 launch of Quantinuum's Sol system is seen as a key milestone.